Joseph C. Galante, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 641 shares at $2.75 ($2K) on 2022-04-21, disclosed to the SEC on 2022-05-06.
Scheduled purchase ($2k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.71 | 56 | $152 | 9.1% |
| 2 | $2.63 | 56 | $147 | 8.8% |
| 3 | $2.69 | 56 | $151 | 9.0% |
| 4 | $2.74 | 56 | $153 | 9.2% |
| 5 | $2.75 | 56 | $154 | 9.2% |
| 6 | $2.73 | 56 |
| $153 |
| 9.1% |
| 7 | $2.62 | 61 | $160 | 9.6% |
| 8 | $2.53 | 61 | $154 | 9.2% |
| 9 | $2.41 | 61 | $147 | 8.8% |
| 10 | $2.51 | 61 | $153 | 9.2% |
| 11 | $2.44 | 61 | $149 | 8.9% |
| Total | $2.61 avg | 641 | $2K | 100% |
| Filing → |
| CPIX | BUY | 2022-12-23 | $3K | — | Filing → |
| CPIX | BUY | 2022-11-18 | $4K | — | Filing → |
| CPIX | BUY | 2022-09-30 | $5K | — | Filing → |